Evidence map›Paper›PMID 31187271›Full record

ArticleMikrochimica acta2019

Fluorescent silver nanoclusters as antibody label in a competitive immunoassay for the complement factor H.

Eva Valencia, María Cruz-Alonso, Lydia Álvarez, Héctor González-Iglesias, Beatriz Fernández, Rosario Pereiro

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Eva ValenciaDepartment of Physical and Analytical Chemistry, University of Oviedo, Julian Clavería, 8, 33006, Oviedo, Spain.
María Cruz-AlonsoDepartment of Physical and Analytical Chemistry, University of Oviedo, Julian Clavería, 8, 33006, Oviedo, Spain.
Lydia ÁlvarezInstituto Universitario Fernández-Vega (Fundación de Investigación Oftalmológica, Universidad de Oviedo), Avda. Dres. Fernández-Vega, 34, 33012, Oviedo, Spain.
Héctor González-IglesiasInstituto Universitario Fernández-Vega (Fundación de Investigación Oftalmológica, Universidad de Oviedo), Avda. Dres. Fernández-Vega, 34, 33012, Oviedo, Spain. h.gonzalez@fio.as.
Beatriz FernándezDepartment of Physical and Analytical Chemistry, University of Oviedo, Julian Clavería, 8, 33006, Oviedo, Spain. fernandezbeatriz@uniovi.es.ORCID 0000-0002-2592-1442
Rosario PereiroDepartment of Physical and Analytical Chemistry, University of Oviedo, Julian Clavería, 8, 33006, Oviedo, Spain.
Universidad de Oviedo · ES

Funding

Agencia Estatal de Investigación CTQ2016-79015-RGobierno del Principado de Asturias IDE/2016/000214Secretaría de Estado de Investigación, Desarrollo e Innovación RYC-2014-14985
6 · The paper itself

Abstract

Silver nanoclusters (AgNCs) were investigated as labels for the development of a fluoroimmunoassay for the complement factor H (CFH). The reductive one-pot synthesis of AgNCs using lipoic acid as a ligand was optimized by varying the concentration of NaBH

Indexed as

AntibodiesComplement Factor HFluorescent DyesFluoroimmunoassayHumansLimit of DetectionMetal NanoparticlesSilverAntibodiesCFH protein, humanComplement Factor HFluorescent DyesSilverCarbodiimideFluoroimmunoassayHuman serumLabellingLipoic acidOne-pot synthesis

Identifiers

PMID31187271
OpenAlexW2949757943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.